View Single Post
Old 07-04-2014, 03:52 AM   #1
News
Senior Member
 
News's Avatar
 
Join Date: Oct 2007
Posts: 20,133
Life-extending treatment for metastatic breast cancer now licenced in UK after one pr

From 3 July 2014, Halaven® (eribulin) is licenced in the UK for the treatment of patients with locally advanced or metastatic breast cancer (MBC) who have progressed after at least one...

More...
News is offline   Reply With Quote